LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Atypical Mycobacterial Infection Presenting as Persistent Skin Lesion in a Patient with Ulcerative Colitis

    Giorgos Bamias / George L. Daikos / Spyros I. Siakavellas / Garyfallia Kaltsa / Stavroula Smilakou / Ioannis Katsogridakis / Irene Vafiadis-Zouboulis / Spiros D. Ladas

    Case Reports in Medicine, Vol

    2011  Volume 2011

    Abstract: Immunosuppressive drugs are commonly used for the treatment of inflammatory bowel disease. Patients receiving immunosuppressants are susceptible to a variety of infections with opportunistic pathogens. We present a case of skin infection with ... ...

    Abstract Immunosuppressive drugs are commonly used for the treatment of inflammatory bowel disease. Patients receiving immunosuppressants are susceptible to a variety of infections with opportunistic pathogens. We present a case of skin infection with Mycobacterium chelonae in a 60-year-old Caucasian woman with ulcerative colitis who had been treated with corticosteroids and azathioprine. The disease manifested with fever and rash involving the right leg. Infliximab was administered due to a presumptive diagnosis of pyoderma gangrenosum, leading to worsening of the clinical syndrome and admission to our hospital. Routine cultures from various sites were all negative. However, Ziehl-Neelsen staining of pus from the lesions revealed acid-fast bacilli, and culture yielded a rapidly growing mycobacterium further identified as M. chelonae. The patient responded to a clarithromycin-based regimen. Clinicians should be aware of skin lesions caused by atypical mycobacteria in immunocompromised patients with inflammatory bowel disease. Furthermore, they should be able to thoroughly investigate and promptly treat these conditions.
    Keywords Medicine ; R
    Subject code 610
    Language English
    Publishing date 2011-01-01T00:00:00Z
    Publisher Hindawi Limited
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit

    Athanasios Skoutelis / Angelos Pefanis / Sotirios Tsiodras / Nikolaos V Sipsas / Moyssis Lelekis / Marios C Lazanas / Panagiotis Gargalianos / George N Dalekos / Emmanuel Roilides / George Samonis / Efstratios Maltezos / Dimitrios Hatzigeorgiou / Malvina Lada / Symeon Metallidis / Athena Stoupis / Georgios Chrysos / Lazaros Karnesis / Styliani Symbardi / Chariclia V Loupa /
    Helen Giamarellou / Ioannis Kioumis / Helen Sambatakou / Epameinondas Tsianos / Maria Kotsopoulou / Areti Georgopali / Klairi Liakou / Stavroula Perlorentzou / Stamatina Levidiotou / Marina Giotsa-Toutouza / Helen Tsorlini-Christoforidou / Ilias Karaiskos / Georgia Kouppari / Eleftheria Trikka-Graphakos / Maria-Anna Ntrivala / Kate Themeli-Digalaki / Anastasia Pangalis / Melina Kachrimanidou / Maria Martsoukou / Stergios Karapsias / Maria Panopoulou / Sofia Maraki / Anagnostina Orfanou / Efthymia Petinaki / Maria Orfanidou / Vasiliki Baka / Antonios Stylianakis / Iris Spiliopoulou / Stavroula Smilakou / Loukia Zerva / Evangelos Vogiatzakis

    PLoS ONE, Vol 12, Iss 8, p e

    The C. DEFINE study.

    2017  Volume 0182799

    Abstract: The correlation of Clostridium difficile infection (CDI) with in-hospital morbidity is important in hospital settings where broad-spectrum antimicrobial agents are routinely used, such as in Greece. The C. DEFINE study aimed to assess point-prevalence of ...

    Abstract The correlation of Clostridium difficile infection (CDI) with in-hospital morbidity is important in hospital settings where broad-spectrum antimicrobial agents are routinely used, such as in Greece. The C. DEFINE study aimed to assess point-prevalence of CDI in Greece during two study periods in 2013.There were two study periods consisting of a single day in March and another in October 2013. Stool samples from all patients hospitalized outside the ICU aged ≥18 years old with diarrhea on each day in 21 and 25 hospitals, respectively, were tested for CDI. Samples were tested for the presence of glutamate dehydrogenase antigen (GDH) and toxins A/B of C. difficile; samples positive for GDH and negative for toxins were further tested by culture and PCR for the presence of toxin genes. An analysis was performed to identify potential risk factors for CDI among patients with diarrhea.5,536 and 6,523 patients were screened during the first and second study periods, respectively. The respective point-prevalence of CDI in all patients was 5.6 and 3.9 per 10,000 patient bed-days whereas the proportion of CDI among patients with diarrhea was 17% and 14.3%. Logistic regression analysis revealed that solid tumor malignancy [odds ratio (OR) 2.69, 95% confidence interval (CI): 1.18-6.15, p = 0.019] and antimicrobial administration (OR 3.61, 95% CI: 1.03-12.76, p = 0.045) were independent risk factors for CDI development. Charlson's Comorbidity Index (CCI) >6 was also found as a risk factor of marginal statistical significance (OR 2.24, 95% CI: 0.98-5.10). Median time to CDI from hospital admission was shorter with the presence of solid tumor malignancy (3 vs 5 days; p = 0.002) and of CCI >6 (4 vs 6 days, p = 0.009).The point-prevalence of CDI in Greek hospitals was consistent among cases of diarrhea over a 6-month period. Major risk factors were antimicrobial use, solid tumor malignancy and a CCI score >6.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2017-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top